Determination of moxifloxacin and its oxidation products with kinetic evaluation under potassium permanganate treatment in acidic solution by ultra-performance liquid chromatography/tandem mass spectrometry

J AOAC Int. 2013 Nov-Dec;96(6):1288-94. doi: 10.5740/jaoacint.12-094.

Abstract

A simple, sensitive, and reproducible ultra-performance LC method for the determination of moxifloxacin (MOXI) oxidation stability under permanganate treatment in acidic conditions (pH 3.0-6.0) was developed. Besides the MOXI peak [retention time (RT) = 2.58], four additional products (RT = 0.86, 0.91, 1.42, and 1.89) were observed in all conditions tested. The oxidation process followed second-order reaction kinetics and depended upon solution acidity. The highest reaction rate constant was observed at pH 3.0, and this value decreased as the pH was increased to 6.0. The oxidation products were characterized, and their fragmentation pathways, derived from MS/MS data, were proposed. Two of these products were identified as hydroxyl derivatives of MOXI and two others as their oxidation product analogs with molecular ions of 418.4 and 416.4 m/z, respectively.

MeSH terms

  • Absorption
  • Aza Compounds / analysis*
  • Aza Compounds / chemistry
  • Chemistry, Pharmaceutical / methods
  • Chromatography, High Pressure Liquid / methods
  • Chromatography, Liquid / methods*
  • Fluoroquinolones
  • Hydrogen-Ion Concentration
  • Ions
  • Kinetics
  • Moxifloxacin
  • Oxidation-Reduction
  • Oxygen / chemistry*
  • Potassium Permanganate / chemistry*
  • Quinolines / analysis*
  • Quinolines / chemistry
  • Tandem Mass Spectrometry / methods*
  • Time Factors

Substances

  • Aza Compounds
  • Fluoroquinolones
  • Ions
  • Quinolines
  • Potassium Permanganate
  • Oxygen
  • Moxifloxacin